Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Womens Health Issues. 2014 Nov 22;25(1):6–12. doi: 10.1016/j.whi.2014.09.004

Figure 1.

Figure 1

Comparing the association of treatment intensification with patient-reported cost-related nonadherence and nonadherence related to side-effects of the medication across genders. After adjustment for age, education, race/ethnicity and insurance status, the test for gender by regimen intensification interaction is significant for nonadherence related to side effects (p=0.048). Error bars represent 95% confidence intervals.